| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |